This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Huiling Wu: Innovator in Antibody Development
Introduction
Huiling Wu is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work focuses on innovative solutions for treating diseases related to the overexpression of human IL-4R.
Latest Patents
Huiling Wu holds a patent for "Antibodies binding to human IL-4R, preparation method therefor and use thereof." This patent discloses antibodies that bind specifically to human IL-4R, featuring identical variable regions and different constant regions. The variable regions are designed to specifically target human IL-4R, while the constant regions influence the overall activity of the antibody through amino acid site mutations. These antibodies have promising clinical applications for treating diseases such as atopic dermatitis and asthma, which are associated with IL-4R overexpression.
Career Highlights
Huiling Wu is currently employed at Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Her role at the company allows her to apply her expertise in antibody development to real-world medical challenges. With her innovative approach, she has positioned herself as a key player in the biotechnology sector.
Collaborations
Huiling Wu collaborates with notable colleagues, including Jie Zhao and Liangfeng Jiang. These partnerships enhance her research and development efforts, contributing to the advancement of therapeutic solutions in the field.
Conclusion
Huiling Wu's work in antibody development showcases her commitment to addressing critical health issues through innovation. Her patent on antibodies targeting human IL-4R highlights her contributions to biotechnology and the potential for significant clinical applications.